TP53 and neoplasm: Apart from wild-type P53, mutant P53 isoforms also display notably carcinogenic effect and are referred to as GOFs (gain of functions), which culminates in chemoresistance to tumor therapies, genomic instability and aberrant deregulation of cell cycle progression [61].